Daiwa Securities Group
MRSN

Daiwa Securities Group’s Mersana Therapeutics MRSN Stock Holding History

Daiwa Securities Group’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16
Closed -$1K – 1365
2023
Q3 		$1K Hold
16
– – ﹤0.01% 1263
2023
Q2 		$1K Hold
16
– – ﹤0.01% 1285
2023
Q1 		$2K Hold
16
– – ﹤0.01% 1221
2022
Q4 		$2K Buy
16
+6
+60% +$1.01K ﹤0.01% 1230
2022
Q3 		$2K Hold
10
– – ﹤0.01% 1237
2022
Q2 		$1K Hold
10
– – ﹤0.01% 1303
2022
Q1 		$1K Hold
10
– – ﹤0.01% 1318
2021
Q4 		$2K Hold
10
– – ﹤0.01% 1288
2021
Q3 		$2K Buy
10
+5
+100% +$1.46K ﹤0.01% 1244
2021
Q2 		$2K Hold
5
– – ﹤0.01% 1144
2021
Q1 		$2K Hold
5
– – ﹤0.01% 1147
2020
Q4 		$3K Buy
+5
New +$2.78K ﹤0.01% 1091
2018
Q4 		– Sell
-5
Closed -$1K – 1169
2018
Q3 		$1K Hold
5
– – ﹤0.01% 1148
2018
Q2 		$2K Hold
5
– – ﹤0.01% 1141
2018
Q1 		$2K Buy
+5
New +$1.97K ﹤0.01% 1130

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return